This portable air disinfection device claims to reduce Coronavirus surrogate by 99.99%

Novaerus - an Irish company that manufactures and sells patented medical-grade, clean air solutions, has claimed that its new portable air disinfection device can reduce MS2 Bacteriophage, a surrogate for SARS-CoV-2 (COVID-19), by 99.99% in 15 minutes. 

Called the Defend 1050, the device combines rapid air disinfection and purification into one safe and portable device. Designed for continuous cleaning of the air in large spaces and rapid remediation in situations with a high risk of infection, the device uses Novaerus patented ultra-low energy plasma technology combined with a triple-stage filtration system from Camfil. 

“Novaerus, specializes in non-chemical air disinfection using patented ultra-low energy plasma devices that has achieved a remarkable feat. The new Defend 1050 is a portable, easy to use device ideal for rapid disinfection and purification of the air in large spaces and high-risk situations such as operating theatres, ICUs, IVF labs, emergency and waiting rooms, schools, offices and construction zones. Our aim is to make this product available at a low cost or even put it out on rent in order to help maximum people in India,” Dilip Patil, Director of Trivector Biomed LLP said said.

WATCH Zee Business TV LIVE Streaming Online

The company claims that its research suggested that clean, disinfected air plays a vital role in preventing the spread of SARS-CoV-2, the virus causing COVID -19. While respiratory droplets are considered the primary transmission route, aerosols are being considered by many health authorities as a possible mode of infection transmission. This advocates that viral particles can remain suspended in the air for long periods and can be inhaled.

“Research and innovation will play a significant role in tackling the Covid-19 pandemic and technologies like these will have a positive impact on the health and wellbeing of patients, families, healthcare workers, and the healthcare system,” Abhinav Bhatia, Director, India & South Asia - Enterprise Ireland said.